HK1035001A1 - Method for enzymatic enantiomer-separation of 3(R)-and 3(s)-hydroxy-1-methyl-4-(2,4,6-trimethoxyphe nyl)-1,2,3,6-tetrahydro-pyridine or its carboxylicacid esters - Google Patents

Method for enzymatic enantiomer-separation of 3(R)-and 3(s)-hydroxy-1-methyl-4-(2,4,6-trimethoxyphe nyl)-1,2,3,6-tetrahydro-pyridine or its carboxylicacid esters

Info

Publication number
HK1035001A1
HK1035001A1 HK01105718A HK01105718A HK1035001A1 HK 1035001 A1 HK1035001 A1 HK 1035001A1 HK 01105718 A HK01105718 A HK 01105718A HK 01105718 A HK01105718 A HK 01105718A HK 1035001 A1 HK1035001 A1 HK 1035001A1
Authority
HK
Hong Kong
Prior art keywords
tetrahydro
pyridine
hydroxy
methyl
separation
Prior art date
Application number
HK01105718A
Other languages
English (en)
Inventor
Wolfgang Holla
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of HK1035001A1 publication Critical patent/HK1035001A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/001—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by metabolizing one of the enantiomers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification
    • Y10S435/816—Enzyme separation or purification by solubility

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyridine Compounds (AREA)
HK01105718A 1998-03-06 2001-08-15 Method for enzymatic enantiomer-separation of 3(R)-and 3(s)-hydroxy-1-methyl-4-(2,4,6-trimethoxyphe nyl)-1,2,3,6-tetrahydro-pyridine or its carboxylicacid esters HK1035001A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19809649A DE19809649A1 (de) 1998-03-06 1998-03-06 Verfahren zur enzymatischen Enantiomeren-Trennung von 3(R)- und 3(S)-Hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)-1,2,3,6-tetrahydro-pyridin bzw. der Carbonsäureester
PCT/EP1999/001113 WO1999045133A1 (de) 1998-03-06 1999-02-20 Verfarhen zur enzymatischen enantiomeren-trennung von 3(r)- und 3(s)-hydroxy-1- methyl-4-(2,4, 6-trimethoxyphenyl)-1, 2,3,6- tetrahydro-pyridin bzw. der carbonsäureester

Publications (1)

Publication Number Publication Date
HK1035001A1 true HK1035001A1 (en) 2001-11-09

Family

ID=7859957

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01105718A HK1035001A1 (en) 1998-03-06 2001-08-15 Method for enzymatic enantiomer-separation of 3(R)-and 3(s)-hydroxy-1-methyl-4-(2,4,6-trimethoxyphe nyl)-1,2,3,6-tetrahydro-pyridine or its carboxylicacid esters

Country Status (23)

Country Link
US (1) US6406912B1 (hu)
EP (1) EP1071807B1 (hu)
JP (1) JP4344089B2 (hu)
KR (1) KR100779864B1 (hu)
CN (1) CN1230554C (hu)
AR (1) AR018574A1 (hu)
AT (1) ATE474061T1 (hu)
AU (1) AU758106B2 (hu)
BR (2) BRPI9908557B8 (hu)
CA (1) CA2322842C (hu)
CY (1) CY1110919T1 (hu)
CZ (1) CZ301944B6 (hu)
DE (2) DE19809649A1 (hu)
DK (1) DK1071807T3 (hu)
ES (1) ES2348394T3 (hu)
HK (1) HK1035001A1 (hu)
HU (1) HU227994B1 (hu)
ID (1) ID27000A (hu)
PL (1) PL195006B1 (hu)
PT (1) PT1071807E (hu)
RU (1) RU2241040C2 (hu)
TR (1) TR200002576T2 (hu)
WO (1) WO1999045133A1 (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0201160A3 (en) 1999-05-13 2004-03-29 Shell Int Research Hydrocarbon conversion process
US7153675B2 (en) 2001-05-15 2006-12-26 Speedel Pharma Ag Process for the preparation of substituted carboxylic esters
CN104278061A (zh) * 2014-10-01 2015-01-14 青岛科技大学 一种生产氟苯基甲基丙酸甲酯的产朊酵母还原法
CN104232700A (zh) * 2014-10-01 2014-12-24 青岛科技大学 一种生物法生产(2r,3s)羟基丙酸甲酯的方法
CA2982928A1 (en) 2015-04-20 2016-10-27 Tolero Pharmaceuticals, Inc. Predicting response to alvocidib by mitochondrial profiling
KR102608921B1 (ko) 2015-05-18 2023-12-01 스미토모 파마 온콜로지, 인크. 생체 이용률이 증가된 알보시딥 프로드러그
CN108289861B (zh) 2015-08-03 2021-11-02 大日本住友制药肿瘤公司 用于治疗癌症的组合疗法
WO2018094275A1 (en) 2016-11-18 2018-05-24 Tolero Pharmaceuticals, Inc. Alvocidib prodrugs and their use as protein kinase inhibitors
WO2018119000A1 (en) 2016-12-19 2018-06-28 Tolero Pharmaceuticals, Inc. Profiling peptides and methods for sensitivity profiling
US11497756B2 (en) 2017-09-12 2022-11-15 Sumitomo Pharma Oncology, Inc. Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1 inhibitor alvocidib
US11034710B2 (en) 2018-12-04 2021-06-15 Sumitomo Dainippon Pharma Oncology, Inc. CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer
US11793802B2 (en) 2019-03-20 2023-10-24 Sumitomo Pharma Oncology, Inc. Treatment of acute myeloid leukemia (AML) with venetoclax failure
CN110577974B (zh) * 2019-09-10 2021-07-20 杭州澳赛诺生物科技有限公司 手性3-羟基-1,2,3,6-四氢吡啶的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2691986B2 (ja) * 1987-08-28 1997-12-17 チッソ株式会社 ピリジン骨格を有する光学活性化合物の製造法
DE3743824C2 (de) * 1987-12-23 1997-03-06 Hoechst Ag Verfahren zur enzymatischen Racematspaltung von racemischen Alkoholen mit/in Vinylestern durch Umesterung
JPH0641075A (ja) * 1990-09-01 1994-02-15 Kazuo Achinami 新規な１，４−ジヒドロピリジン化合物及びその製造方法
JPH05192145A (ja) * 1991-04-02 1993-08-03 Hoechst Ag 固定化生体触媒、その製造およびカラムリアクター中でのエステル合成におけるその使用
JPH0690790A (ja) * 1992-09-08 1994-04-05 Mercian Corp 光学活性１，４−ジヒドロピリジン−３，５−ジカルボン酸・モノエステル誘導体の製造方法
DE19802449A1 (de) * 1998-01-23 1999-07-29 Hoechst Marion Roussel De Gmbh Verfahren zur Herstellung von (-)cis-3-Hydroxy-1-methyl-4-(2,4,6-trimethoxypyhenyl)-piperidin

Also Published As

Publication number Publication date
CN1292034A (zh) 2001-04-18
HUP0101795A3 (en) 2004-03-01
JP2002505112A (ja) 2002-02-19
RU2241040C2 (ru) 2004-11-27
CZ20003223A3 (cs) 2000-11-15
PT1071807E (pt) 2010-09-29
KR100779864B1 (ko) 2007-11-27
AU758106B2 (en) 2003-03-13
AU2927599A (en) 1999-09-20
ATE474061T1 (de) 2010-07-15
HUP0101795A2 (hu) 2001-09-28
BR9908557A (pt) 2000-11-21
ES2348394T3 (es) 2010-12-03
EP1071807B1 (de) 2010-07-14
KR20010041643A (ko) 2001-05-25
EP1071807A1 (de) 2001-01-31
CA2322842C (en) 2011-04-05
WO1999045133A1 (de) 1999-09-10
HU227994B1 (en) 2012-08-28
AR018574A1 (es) 2001-11-28
PL342877A1 (en) 2001-07-16
TR200002576T2 (tr) 2000-11-21
BRPI9908557B8 (pt) 2021-05-25
CY1110919T1 (el) 2015-06-10
CN1230554C (zh) 2005-12-07
US6406912B1 (en) 2002-06-18
DE59915183D1 (de) 2010-08-26
DE19809649A1 (de) 1999-09-09
BRPI9908557B1 (pt) 2018-09-18
ID27000A (id) 2001-02-22
DK1071807T3 (da) 2010-11-08
CZ301944B6 (cs) 2010-08-11
CA2322842A1 (en) 1999-09-10
PL195006B1 (pl) 2007-07-31
JP4344089B2 (ja) 2009-10-14

Similar Documents

Publication Publication Date Title
AU757941C (en) Method for producing metallurgical coke
PL341294A1 (en) Method of synthesising 1,3-dioles
HK1049731B (zh) 記錄方法
AU5311296A (en) 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles: new 5-ht1f agonists
HK1035001A1 (en) Method for enzymatic enantiomer-separation of 3(R)-and 3(s)-hydroxy-1-methyl-4-(2,4,6-trimethoxyphe nyl)-1,2,3,6-tetrahydro-pyridine or its carboxylicacid esters
IL173393A0 (en) 4-carboxyamino-2- substituted-1,2,3,4- tetrahydroquinolines as cetp inhibitors
SI1114033T1 (en) 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as cetp inhibitors
AU1831597A (en) Methods and compositions for inhibiting hexokinase
GR3030407T3 (en) Naphthyl compounds, intermediates, compositions, and methods
AU1740900A (en) Method of inhibiting angiogenesis
PL330753A1 (en) Method of obtaining 2,3-dihalogenopropanols
IL139849A0 (en) Method for making 4-carboxyamino-2-substituted 1,2,3,4-tetrahydroquinoline
ZA971735B (en) Novel esters of 1,4-disubstituted piperidine derivatives
PL313204A1 (en) Derivatives of piperidine, method of obtaining them
AU2243797A (en) Methods and compositions for inhibiting hexokinase
AU4370797A (en) Process for obtaining titanium or other metals using shuttle alloys
HK1122646A1 (en) Reproducing method
PL344390A1 (en) Method of obtaining derivatives of 1,4-dihydropyridine
ZA96702B (en) 4-(1H-indol-1-yl)-1-piperidinyl derivatives.
HK1030981A1 (en) Timing block or disc and method for its production
AU5101798A (en) Method for oral administration of buspirone
AU1788800A (en) Derivative of paroxetine
GR3033316T3 (en) Substituted 4-(6-fluoro-[1H]-indol-3-yl)-1,2,3,6-tetrahydropyridine for the treatment of CNS-disorders
AU2219697A (en) Compositions and methods for inhibiting clot formation
AU5655798A (en) Suspension crystallization method

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20190219